Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The nucleus basalis in Huntington's disease.

A W Clark, I M Parhad, S E Folstein

    Neurology
    |October 1, 1983
    PubMed
    Summary

    Alzheimer's disease dementia involves nucleus basalis of Meynert (nbM) neuron loss, unlike Huntington's disease. This study confirms no significant nbM neuron loss in Huntington's disease patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Intermediate-range order in permanently densified GeO2 glass.

    Physical review letters·2003
    Same author

    Microscopic dynamics of liquid aluminum oxide.

    Science (New York, N.Y.)·2003
    Same author

    Effects of anti-odor automobile air-conditioning system products on adherence of Serratia marcescens to aluminum.

    Journal of industrial microbiology & biotechnology·2002
    Same author

    Genetically engineered models relevant to neurodegenerative disorders: their value for understanding disease mechanisms and designing/testing experimental therapeutics.

    Journal of molecular neuroscience : MN·2002
    Same author

    beta-Amyloid peptide vaccination results in marked changes in serum and brain Abeta levels in APPswe/PS1DeltaE9 mice, as detected by SELDI-TOF-based ProteinChip technology.

    DNA and cell biology·2002
    Same author

    Choroid plexus carcinoma presenting as an intraparenchymal mass.

    Journal of neurosurgery·2002

    Area of Science:

    • Neuroscience
    • Neuropathology
    • Neurodegenerative Diseases

    Background:

    • The nucleus basalis of Meynert (nbM) is the primary source of cholinergic input to the cerebral cortex.
    • Reduced cortical choline acetyltransferase (CAT) activity in Alzheimer's disease (AD) correlates with nbM neuron loss.
    • Huntington's disease (HD) does not exhibit a loss of cortical CAT activity.

    Purpose of the Study:

    • To quantitatively assess neuron counts in the nbM of Huntington's disease patients.
    • To compare cytologic changes in nbM neurons of HD patients with controls.
    • To investigate the relationship between nbM integrity and cortical CAT activity in different dementias.

    Main Methods:

    • Quantitative histological analysis of nucleus basalis of Meynert neurons.

    Related Experiment Videos

  • Cytologic examination of nbM neurons in Huntington's disease and control cases.
  • Comparison of neuron counts and cellular morphology between patient groups.

    • Main Results:

    • No significant loss of neurons was found in the nucleus basalis of Meynert in Huntington's disease patients.
    • Cytologic changes in nbM neurons of HD patients were not significantly different from controls.
    • Findings support the hypothesis linking nbM neuron dysfunction/death to reduced neocortical CAT activity in dementia.

    Conclusions:

    • Huntington's disease dementia is not characterized by nucleus basalis of Meynert depopulation.
    • Dementias with reduced neocortical CAT activity involve nbM pathology, while those with normal CAT activity do not.
    • The integrity of the nbM is crucial for maintaining cortical cholinergic function and cognitive health.